Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathies

OBJECTIVE: To define the clinicopathologic features and diagnostic utility associated with anti‐cytosolic 5′‐nucleotidase 1A (NT5C1A) antibody seropositivity in idiopathic inflammatory myopathies (IIMs). METHODS: Anti‐NT5C1A antibody status was clinically tested between 2014 and 2019 in the Washingt...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Clin Transl Neurol
Autors principals: Ikenaga, Chiseko, Findlay, Andrew R., Goyal, Namita A., Robinson, Sarah, Cauchi, Jonathan, Hussain, Yessar, Wang, Leo H., Kershen, Joshua C., Beson, Brent A., Wallendorf, Michael, Bucelli, Robert C., Mozaffar, Tahseen, Pestronk, Alan, Weihl, Conrad C.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7951108/
https://ncbi.nlm.nih.gov/pubmed/33556224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51294
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars